Will Medicare Cover Provenge? A Dendreon “Hockey Stick” Event Approaches
While winter is approaching and the hockey season has already begun for sports fans, another kind of hockey related event is approaching
(more)
October 14, 2010
August 24, 2010
Beyond the Tipping Point: Medicare Will Control the Rising Cost of Cancer Drugs
The question is no longer whether or not Medicare will do it but when and how. The initiation of a National Coverage Decision
(more)
July 29, 2010
Does Folotyn® work in NSCLC? Allos Therapeutics Reports Phase 2 Results
On Wednesday the 28th Allos announced the results of their randomized phase 2 study comparing Folotyn
(more)
July 12, 2010
Buying Opportunities? Dendreon; Antisoma
On July 1st CMS announced that Dendreon’s Provenge® will undergo a National Coverage Determination (NCD).
(more)
June 29, 2010
Catch a rising star.
This past ASCO in Chicago was something like the 18th or 19th one that I have attended, and it has grown from a few thousand physicians to
(more)